TRX818
CAS No. 1256037-58-7
TRX818( —— )
Catalog No. M17224 CAS No. 1256037-58-7
TRX-818 is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 50 | In Stock |
|
| 5MG | 88 | In Stock |
|
| 10MG | 143 | In Stock |
|
| 25MG | 216 | In Stock |
|
| 50MG | 333 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTRX818
-
NoteResearch use only, not for human use.
-
Brief DescriptionTRX-818 is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
-
DescriptionTRX-818 is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
Targetc-Met/HGFR
-
RecptorOthers
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1256037-58-7
-
Formula Weight393.21
-
Molecular FormulaC16H11FNNa2O5P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESc12c(c(c(cc1)OC)P(=O)([O-])[O-])c(=O)cc([nH]2)c1cc(ccc1)F.[Na+].[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PHA-665752
PHA-665752 is a potent, selective, ATP-competitive c-Met inhibitor with Ki/IC50 of 4/9 nM.
-
SU11274
SU11274 (PKI-SU11274) is a potent, selective, ATP-competitive c-Met kinase inhibitor with IC50 of 20 nM.
-
Tyrosine kinase inhi...
Tyrosine kinase inhibitor is a tyrosine kinase inhibitor used in combination with fragmenting aromatic nitrogen compounds as antiproliferative agents.
Cart
sales@molnova.com